XNAS: GALT
Galectin Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (G...
Read More
4.22
0.26
(6.57%)
158.9K
XNAS Volume
XNAS 22 Sep, 2026 2:04 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Galectin Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..